Background: Enforcement of sustainable and green chemistry protocols has seen colossal surge in recent times, the development of an effective, eco-friendly, simple and novel methodologies towards the synthesis of valuable synthetic scaffolds and drug intermediates. Recent advances in technology have now a more efficient means of heating reactions that made microwave energy. Efforts to synthesize novel heterocyclic molecules of biological importance are in continuation. Microwave irradiation is well known to promote the synthesis of a variety of organic and inorganic compounds. The aim of current study was to conceivea mild base mediated preparation of novel Schiff base of 2-Acetylpheno with trimethoprim drug (H2TPBD) and its complexes with Cu(II),Co(II),Zn(II),Cd(II) and Ni(II). Method: The products are likening with traditional processes for reaction time and their yield. (H2TPBD) and the complexes were diagnosed by spectroscopic (Mass, NMR, UV–vis, IR spectral studies, analytical and magnetic data. Results: All complexes were found to be six co-ordinate mono-hydrate as[M(TPBD)(H2O)] [1:1(ligand:metal) ratio] type. The complexes exhibited biological activity against (B.subtilis, P.aeruginosa, C.albicansand Staphylococcus aureus) bacterial strains as compared to (H2TPBD). The antibacterial efficiency showed the following trend: M(II)-complexes ˃ (H2TPBD) ˃ parent drugs. Cu(II), Co(II), Zn(II), Cd(II)andNi(II) complexes had good antioxidant efficiencies than the free ligand (H2TPBD). DNA binding study of complexes with (CT)-DNA utilizing binding nature of the complexes with CT DNA has moreover inveterate by viscometer and emission which then bespoken that complexes bound with CT DNA. The complexestook effective scavenging impact during the DPPH process. Conclusion: [H2TPBD] has been prepared by the condensation of trimethoprim drug and Acetylphenol and characterized by electronic absorption spectra, 1H and 13C-NMR and IR,mass UV-spectroscopies.
(1)
(1)
It is well known that monotherapy does not provide therapeutic response in all hypertensive. Somepatients show an excellent response, while in others there is a poor response. Combinationantihypertensive therapy is administered when blood pressure is inadequately controlled bymonotherapy to achieve a balanced and additive antihypertensive effect with minimum adverse effects.Both angiotensin converting enzyme (ACE) inhibitors and dihydropyridine type of calcium antagonistsare well established and widely used in monotherapy. An understanding of differences in themechanism of action of these agents allows a logical approach for the use of these agents as acombination therapy. This study was designed to evaluate the possible beneficial
... Show More
Olanzapine (OLZ) is classified as a typical antipsychotic drug utilized for the treatment of schizophrenia. Its oral bioavailability is 60% due to its low solubility and pre-systemic metabolism. Hence, the present work aims to formulate and evaluate OLZ nanoparticles dissolving microneedles (MNs) for transdermal delivery to overcome the problems associated with drug administration orally. OLZ nanoparticles were prepared by the nanoprecipitation method. The optimized OLZ nanoparticle formula was utilized for the fabrication of dissolving MNs by loading OLZ nanodispersion into polydimethylsiloxane (PDMS) micromould cavities, followed by casting the polymeric solution of polyvinylpyrrolidone(PVP-K30) and polyvinyl alcohol (PVA) to form
... Show More
Diabetic nephropathy is characterized by persistent microalbuminuria and metabolic changes that decline renal functions. Researchers have been prompted to explore new biomarkers such as KIM-1 and nephrin that may enhance the identification of disease. Objective: To Evaluate biomarker levels of kidney injury molculre-1 (KIM-1) concentration and nephrin as early and sensitive markers of nephropathy in type 2 diabetic patients. Method: One hundred T2DM patients were included in a cross-sectional study at the specialized center for endocrinology and diabetes, Baghdad. The first group includes 50 diabetic nephropathy (DN) patients, and the second group includes 50 T2DM patients without DN. Biochemical and clinical parameters were reported for pa
... Show More
(1)
(1)
(5)
(4)
(5)
(5)
(17)
(14)